WHO Issues Guidance On Fungal Disease

The World Health Organization (WHO) has released new guidance aimed at helping member states address the growing burden of fungal disease and the escalating problem of antifungal resistance. The guidance, part of WHO’s broader antimicrobial resistance strategy, highlights the need for stronger surveillance, improved diagnostic capacity, and coordinated treatment protocols in countries where fungal infections remain largely unaddressed in national health plans.

Key recommendations include establishing national fungal disease surveillance systems, expanding access to rapid diagnostic tests for common pathogens such as *Candida*, *Aspergillus*, and *Mucorales*, and implementing antifungal stewardship programmes to curb inappropriate use of existing drugs. WHO also stresses the importance of integrating fungal disease control into existing public health initiatives, training healthcare workers, and ensuring supply chains for essential antifungal medications. The guidance is based on recent data indicating that fungal infections contribute to millions of deaths worldwide, particularly among immunocompromised patients and those with chronic illnesses.

By adopting the WHO framework, countries can better quantify the impact of fungal diseases, allocate resources more effectively, and reduce mortality associated with resistant infections. The organization urges national governments to incorporate these measures into their health policies, thereby turning a neglected threat into a prioritized public health objective.